Searchable abstracts of presentations at key conferences in endocrinology

ea0032p190 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

Changes in lipid profile and markers of metabolic syndrome after 3 years of testosterone-therapy in female-to-male transsexuals

Becerra Antonio , Menacho Miriam , Perez-Lopez Gilberto , Villar Rosa , Del Rey Jose Manuel , Asenjo Nuria , Lucio Maria Jesus , Rodriguez-Molina Jose Miguel , Llopis Jose Luis

Introduction: Different studies have published that testosterone therapy in men and women results in decreased HDL cholesterol and increased LDL cholesterol, and therefore an increased cardiovascular risk.Aims: To determine whether testosterone therapy has this effect on lipid parameters and markers of metabolic syndrome (MetSyn) in female-to-male transsexuals (FMT).Material and methods: We studied 50 FMT, aged 27.8±7.6 years,...